Clinical Features of Untreated Type 2 Macular Telangiectasia and Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Macular Neovascularization

Clinical Features of Untreated Type 2 Macular Telangiectasia and Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Macular Neovascularization

Objectives:To compare best corrected visual acuity (BCVA), central macular thickness (CMT), and central choroidal thickness (CCT) in patients with type 2 macular telangiectasia (MacTel 2) and a control group and to evaluate the efficacy of intravitreal anti-vascular endothelial growth factor (anti-V...

Full description

Bibliographic Details
Main Authors: Müge Çoban Karataş, Gürsel Yılmaz, Aslıhan Yüce Sezen, Çağla Sarıtürk
Format: Article
Language:English
Published: Galenos Yayinevi 2022-02-01
Series:Türk Oftalmoloji Dergisi
Subjects:
macular telangiectasia
macular neovascularization
anti-vegf treatment
Online Access: http://www.oftalmoloji.org/archives/archive-detail/article-preview/clinical-features-of-untreated-type-2-macular-tela/50958

Internet

http://www.oftalmoloji.org/archives/archive-detail/article-preview/clinical-features-of-untreated-type-2-macular-tela/50958

Similar Items